Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

University of Chicago Medical Center, Chicago, Illinois, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:Chicago, Illinois
Treatments:ChemotherapyHospital:University of Chicago Medical Center
Drugs:Journal:Link
Date:Feb 2001

Description:

Patients: This Phase II study involved 17 patients with malignant mesothelioma.

Treatment: The treatment consisted of the chemotherapy drug, gemcitabine.

Toxicity: Two patients died without documentation of progressive disease and at least one of these deaths was considered related to drug toxicity and disease progression. In addition, grade 3-4 toxicities included hematologic, infection, dyspnea, edema, malaise/fatigue, cerebellar, cardiac dysrhythmia, and hyponatremia.

Results: There were no complete or partial responses and the median survival time was 4.7 months.

Correspondence: Hedy L. Kindler, MD




Back